Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Also known as: Hormone Sensitive Metastatic Prostate Cancer / Metastatic Hormone Sensitive Prostate Cancer / Metastatic Hormone-sensitive Prostate Cancer

DrugDrug NameDrug Description
DB05812AbirateroneAn antiandrogen used in the treatment of metastatic castration-resistant prostate cancer and metastatic high-risk castration-sensitive prostate cancer.
DB12941DarolutamideAn androgen receptor antagonist used for castration-resistant, non-metastatic prostate cancer and metastatic hormone-sensitive prostate cancer.
DrugDrug NamePhaseStatusCount
DB11901Apalutamide0Recruiting1
DB12941Darolutamide0Recruiting1
DB08899Enzalutamide0Recruiting1
DB06186Ipilimumab1Completed1
DB09035Nivolumab1Completed1
DB01248Docetaxel1 / 2Withdrawn1
DB05812Abiraterone2Not Yet Recruiting1
DB12941Darolutamide2Active Not Recruiting1
DB01248Docetaxel2Recruiting1
DB08899Enzalutamide2Not Yet Recruiting1
DB12257Platinum2Recruiting1
DB15566Prednisolone acetate2Recruiting1
DB16065Proxalutamide2Completed1
DB01248Docetaxel2 / 3Active Not Recruiting1
DB06186Ipilimumab2 / 3Active Not Recruiting1
DB09035Nivolumab2 / 3Active Not Recruiting1
DB05812Abiraterone3Recruiting1
DB11901Apalutamide3Recruiting1
DB06772Cabazitaxel3Recruiting1
DB12218Capivasertib3Recruiting1
DB00958Carboplatin3Recruiting1
DB12941Darolutamide3Completed1
DB12941Darolutamide3Recruiting2
DB01248Docetaxel3Active Not Recruiting1
DB01248Docetaxel3Completed1
DB01248Docetaxel3Recruiting2
DB08899Enzalutamide3Active Not Recruiting4
DB08899Enzalutamide3Recruiting1
DB11793Niraparib3Recruiting1
DB09037Pembrolizumab3Active Not Recruiting2
DB00635Prednisone3Recruiting1
DB08913Radium Ra 223 dichloride3Recruiting1
DB11901ApalutamideNot AvailableRecruiting2
DB12941DarolutamideNot AvailableNot Yet Recruiting1
DB08899EnzalutamideNot AvailableRecruiting1